Torrent Pharmaceuticals Limited has informed the Exchange regarding 'Disclosure under Regulation 30 and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended ( Listing Regulations ).'.
TORNTPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Torrent Pharmaceuticals has signed a Share Purchase Agreement on 3rd July 2025 to buy up to 38,75,056 equity shares (2.41% on a fully diluted basis) of J.B. Chemicals & Pharmaceuticals Limited from 48 of JB Chemicals' employees who are exercising their stock options. The price is fixed at ₹1,600 per share, taking the total cash consideration to approximately ₹620.09 crore. This is part of Torrent's earlier announced plan (29th June 2025) to acquire a controlling stake in JB Chemicals, and a further 0.39% (up to 6,24,726 shares) from other employees may follow under separate agreements. The deal is conditional on shareholder approval, regulatory clearances, and Torrent first completing the acquisition of the controlling stake. The filing clarifies this is not a related-party transaction and promoters have no interest in these selling employees.
This deepens Torrent Pharma's move toward taking a controlling stake in JB Chemicals & Pharmaceuticals, signalling a significant consolidation play in the Indian pharma space. For Torrent shareholders, this means a sizeable cash outflow (~₹620 crore now, potentially more) and integration risk, but also the prospect of expanded scale and market share if the broader deal closes.